Ripretinib Side Effects
Medically reviewed by Drugs.com. Last updated on Jun 25, 2024.
Applies to ripretinib: oral tablet.
Precautions
It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Blood tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using this medicine to make sure you are not pregnant. Female patients should use an effective form of birth control during treatment with this medicine and for at least 1 week after the last dose. Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 1 week after the last dose. If you think you have become pregnant while using the medicine, tell your doctor right away.
Ripretinib may cause a serious skin problem called hand-foot syndrome or palmar-plantar erythrodysesthesia syndrome. Tell your doctor right away if you have a rash that does not go away or redness, pain, swelling, bleeding, or blisters on the palms of your hands or soles of your feet.
This medicine may increase your risk for new skin cancers (eg, cutaneous squamous cell carcinoma, melanoma). Check with your doctor right away if you have a new wart, skin sore or reddish bump that bleeds or does not heal, or change in size or color of a mole.
Your blood pressure might get too high while you are using this medicine. This may cause headaches, dizziness, or blurred vision. If you think your blood pressure is too high, call your doctor right away.
Check with your doctor right away if you have chest pain or discomfort, dilated neck veins, irregular breathing, irregular heartbeat, swelling of the face, fingers, feet, or lower legs, unusual tiredness or weakness, or weight gain. These could be symptoms of a heart problem (eg, cardiac failure, acute left ventricular failure, diastolic dysfunction, ventricular hypertrophy).
This medicine may affect the way your body heals from cuts and wounds. Make sure any doctor who treats you knows that you are using this medicine. You may need to stop using this medicine several days before and after having surgery.
This medicine may make your skin more sensitive to sunlight. Use a sunscreen when you are outdoors. Avoid exposure to direct sunlight, sunlamps, or other ultraviolet radiation during treatment and for at least 1 week after the last dose.
If you plan to have children, talk with your doctor before using this medicine. Some men using this medicine have become infertile (unable to have children).
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of ripretinib
Along with its needed effects, ripretinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ripretinib:
More common side effects
- blistering, peeling, loosening of the skin
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blurred vision
- chest tightness
- constipation
- diarrhea
- difficult or labored breathing
- dizziness
- headache
- nausea or vomiting
- nervousness
- pounding in the ears
- rash, redness, swelling, pain, or ulceration of the skin
- scaling of the skin on the hands and feet
- slow or fast heartbeat
- stomach pain
- tingling of the hands or feet
- unusual weight gain or loss
Less common side effects
- change in size, shape, or color of existing mole
- chest pain or discomfort
- decreased urine output
- dilated neck veins
- irregular breathing
- irregular heartbeat
- mole that leaks fluid or bleeds
- new mole
- pale skin
- trouble breathing
- unusual bleeding or bruising
- unusual tiredness or weakness
Rare side effects
- increased sensitivity of the skin to sunlight
- redness or other discoloration of the skin
- severe sunburn
Other side effects of ripretinib
Some side effects of ripretinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- difficulty in moving
- dry or itching skin
- joint pain or swelling
- lack or loss of strength
- loss of appetite
- loss or thinning of the hair
- muscle pains or stiffness
- swelling or inflammation of the mouth
For healthcare professionals
Applies to ripretinib: oral tablet.
General adverse events
The most common adverse reactions are alopecia, fatigue, nausea, abdominal pain, constipation, myalgia, diarrhea, decreased appetite, palmar-plantar erythrodysesthesia syndrome (PPES), and vomiting.[Ref]
Cardiovascular
- Very common (10% or more): Hypertension (up to 19.4%)
- Common (1% to 10%): Cardiac dysfunction (e.g., cardiac failure, acute left ventricular failure, diastolic dysfunction, ventricular hypertrophy), cardiac ischemic events (including acute coronary syndrome and fatal cardiac arrest or myocardial infarction)[Ref]
Dermatologic
- Very common (10% or more): Alopecia (up to 52%), palmar-plantar erythrodysesthesia syndrome (PPES) (up to 29.8%), dry skin (up to 17%), pruritus (11%)
- Common (1% to 10%): Photosensitivity
- Frequency not reported: Dermatosis[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (39%), abdominal pain (36%), constipation (34%), lipase increased (32%), diarrhea (28%), vomiting (21%), serum amylase increased (13%), stomatitis (11%)[Ref]
Hematologic
- Common (1% to 10%): Anemia (3.5%)[Ref]
Hepatic
- Very common (10% or more): Increased bilirubin (22%), increased alanine aminotransferase (ALT) (12%)[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (27%)[Ref]
Musculoskeletal
- Very common (10% or more): Myalgia (up to 37.8%), arthralgia (up to 21.2%), muscle spasms (15%)
- Frequency not reported: Arthritis[Ref]
Nervous system
- Very common (10% or more): Headache (up to 20.7%)
- Frequency not reported: Hyperesthesia[Ref]
Oncologic
Other
- Very common (10% or more): Fatigue (up to 51%), increased creatine phosphokinase (CPK) (21%), peripheral edema (up to 17%), asthenia (13%), increased triglycerides (26%), decreased phosphate (26%), decreased calcium (23%), weight loss (up to 26.5%), decreased sodium (17%), increased activated partial thromboplastin time (35%), increased international normalized ration (INR) (21%), decreased neutrophil count (10%), increased lipase (up to 32%), increased serum amylase (13%)
- Common (1% to 10%): Physical health deterioration[Ref]
Psychiatric
- Frequency not reported: Agitation[Ref]
Renal
- Very common (10% or more): Increased creatinine (16%)[Ref]
Respiratory
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Stivarga
Stivarga (regorafenib) is used to treat metastatic colorectal cancer, gastrointestinal stromal ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Sutent
Sutent is a cancer medicine that is used to treat certain types of advanced or progressive tumors ...
Qinlock
Qinlock (ripretinib) is used for the treatment of patients with advanced gastrointestinal stromal ...
Imkeldi
Imkeldi is used to treat specific types of leukemia (blood cancer), bone marrow disorders ...
Avapritinib
Avapritinib systemic is used for gastrointestinal stromal tumor, systemic mastocytosis
Sunitinib
Sunitinib systemic is used for gastrointestinal stromal tumor, pancreatic cancer, renal cell carcinoma
Regorafenib
Regorafenib systemic is used for colorectal cancer, gastrointestinal stromal tumor, hepatocellular ...
References
1. (2023) "Product Information. Qinlock (ripretinib)." Deciphera Pharmaceuticals (Netherlands) B.V.
2. (2022) "Product Information. Qinlock (ripretinib)." Specialised Therapeutics Australia Pty Ltd
3. (2023) "Product Information. Qinlock (ripretinib)." Deciphera Pharmaceuticals
More about ripretinib
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Ripretinib side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.